Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters











Publication year range
1.
Am J Med Sci ; 362(4): 418-423, 2021 10.
Article in English | MEDLINE | ID: mdl-34161825

ABSTRACT

Coronavirus disease 2019 (COVID-19) has been associated with an increased risk of venous and arterial thrombotic disease. Although pulmonary embolism has been the most common thrombotic complication, there have been recent reports of COVID-19-associated large-vessel ischemic stroke, acute upper- and lower-limb ischemia, as well as infarctions of the abdominal viscera, including renal, splenic, and small bowel infarctions. Here, we describe a case of splenic infarction (SI) associated with aortic thrombosis, which evolved despite the prophylactic use of low-molecular-weight heparin (LMWH), in a 60-year-old female patient with COVID-19. The patient was treated clinically with a therapeutic dose of LMWH, followed by warfarin, and eventually presented a favorable outcome. We also present a review of the literature regarding SI in patients with COVID-19.


Subject(s)
Aortic Diseases/virology , COVID-19/complications , Splenic Infarction/virology , Thrombosis/virology , COVID-19/diagnostic imaging , Computed Tomography Angiography , Female , Humans , Middle Aged , Splenic Infarction/diagnostic imaging
2.
Vasc Endovascular Surg ; 55(3): 273-276, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33034240

ABSTRACT

Since the outbreak of the COVID-19 pandemic, increasing evidence suggests that infected patients present a high incidence of thrombotic complications. We report a 67-year-old-woman admitted for severe acute respiratory syndrome coronavirus 2 infection. Chest CT images showed bilateral ground glass opacities, bilateral pulmonary embolism, right ventricular clot in transit and 2 thoracic aortic mural thrombus. Therapy was initiated with subcutaneous low-molecular-weight heparin, and the patient was discharged at 20 days asymptomatic. Complete resolution of the aortic thrombus was observed in a 1-month surveillance CT angiogram. Our case illustrates vascular complications in a COVID-19 patient and its effective treatment with anticoagulation.


Subject(s)
Aortic Diseases/virology , COVID-19/complications , COVID-19/diagnostic imaging , Heart Diseases/virology , Pulmonary Embolism/virology , Thrombosis/virology , Aged , Aortic Diseases/diagnostic imaging , Aortic Diseases/therapy , COVID-19/therapy , Female , Heart Diseases/diagnostic imaging , Heart Diseases/therapy , Humans , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/therapy , Thrombosis/diagnostic imaging , Thrombosis/therapy
4.
J Infect Dis ; 218(suppl_2): S107-S112, 2018 09 22.
Article in English | MEDLINE | ID: mdl-30247600

ABSTRACT

Varicella zoster virus (VZV) is a ubiquitous, exclusively human alphaherpesvirus that produces varicella then becomes latent in ganglionic neurons. In elderly and immunocompromised individuals, VZV reactivates and typically produces herpes zoster. Studies of patients with VZV vasculopathy have identified key clinical, imaging, and laboratory features to assist in diagnosis and treatment. Complementary studies have further expanded the spectrum of VZV vasculopathy to include the extracranial circulation and identified mechanisms contributing to its pathogenesis. Given our increasing aging population and recognition that VZV reactivation manifesting as zoster is a risk factor for stroke and myocardial infarction, recognition of VZV as a potential cause of vascular disease with or without associated zoster rash is essential to decrease associated morbidity and mortality because VZV vasculopathy can be treated with antiviral therapy.


Subject(s)
Arteritis/virology , Herpes Zoster/pathology , Herpesvirus 3, Human , Stroke/etiology , Antiviral Agents/therapeutic use , Aortic Diseases/virology , Herpes Zoster/complications , Herpes Zoster/drug therapy , Humans , Risk Factors , Stroke/virology
5.
Comp Med ; 65(5): 369-81, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26473341

ABSTRACT

Macrophages play a key role in the development of atherosclerosis. Murine noroviruses (MNV) are highly prevalent in research mouse colonies and infect macrophages and dendritic cells. Our laboratory found that MNV4 infection in mice lacking the LDL receptor alters the development of atherosclerosis, potentially confounding research outcomes. Therefore, we investigated whether MNV4 likewise altered atherosclerosis in ApoE(-/-) mice. In the presence of oxidized LDL, MNV4 infection of ApoE(-/-) bone marrow-derived macrophages increased the gene expression of the inflammatory markers inducible nitric oxide synthase, monocyte chemoattractant protein 1, and IL6. In addition, proteins involved in cholesterol transport were altered in MNV4-infected ApoE -/- bone marrow-derived macrophages and consisted of increased CD36 and decreased ATP-binding cassette transporter A1. MNV4 infection of ApoE(-/-) mice at 12 wk of age (during the development of atherosclerosis) had a variable effect on atherosclerotic lesion size. In one study, MNV4 significantly increased atherosclerotic plaque area whereas in a second study, no effect was observed. Compared with controls, MNV4-infected mice had higher circulating Ly6C-positive monocytes, and viral RNA was detected in the aortas of some mice, suggesting potential mechanisms by which MNV4 alters disease progression. Plaque size did not differ when ApoE -/- mice were infected at 4 wk of age (early during disease development) or in ApoE -/- mice maintained on a high-fat, high-cholesterol diet. Therefore, these data show that MNV4 has the potential to exert a variable and unpredictable effect on atherosclerosis in ApoE(-/-) mice. We therefore propose that performing experiments in MNV-free mouse colonies is warranted.


Subject(s)
Aorta/virology , Aortic Diseases/virology , Apolipoproteins E/deficiency , Atherosclerosis/virology , Caliciviridae Infections/virology , Macrophages/virology , Norovirus/pathogenicity , Age Factors , Animals , Aorta/metabolism , Aorta/pathology , Aortic Diseases/genetics , Aortic Diseases/metabolism , Aortic Diseases/pathology , Apolipoproteins E/genetics , Atherosclerosis/genetics , Atherosclerosis/metabolism , Atherosclerosis/pathology , Cholesterol, Dietary/metabolism , Cytokines/metabolism , Diet, High-Fat , Disease Models, Animal , Disease Progression , Genetic Predisposition to Disease , Inflammation Mediators/metabolism , Lipoproteins, LDL/metabolism , Macrophages/metabolism , Macrophages/pathology , Male , Mice , Mice, Knockout , Phenotype , Plaque, Atherosclerotic , RAW 264.7 Cells
7.
J Cardiovasc Transl Res ; 6(1): 54-64, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23192592

ABSTRACT

Multiple studies suggest an association between cytomegalovirus (CMV) infection and atherogenesis; however, the molecular mechanisms by which viral infection might exacerbate atherosclerosis are not well understood. Aortas of MCMV-infected and uninfected Apo E knockout (KO) mice were analyzed for atherosclerotic lesion development and differential gene expression. Lesions in the infected mice were larger and showed more advanced disease compared to the uninfected mice. Sixty percent of the genes in the MAPK pathway were upregulated in the infected mice. p38 and ERK 1/2 MAPK genes were 5.6- and 2.0-fold higher, respectively, in aortas of infected vs. uninfected mice. Levels of VCAM-1, ICAM-1, and MCP-1 were ~2.0-2.6-fold higher in aortas of infected vs. uninfected mice. Inhibition of p38 with SB203580 resulted in lower levels of pro-atherogenic molecules and MCMV viral load in aortas of infected mice. MCMV-induced upregulation of p38 may drive the virus-induced acceleration of atherogenesis observed in our model.


Subject(s)
Aorta/enzymology , Aorta/virology , Aortic Diseases/etiology , Apolipoproteins E/deficiency , Herpesviridae Infections/virology , Muromegalovirus/pathogenicity , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Aorta/drug effects , Aorta/pathology , Aortic Diseases/enzymology , Aortic Diseases/genetics , Aortic Diseases/pathology , Aortic Diseases/virology , Apolipoproteins E/genetics , Chemokine CCL2/metabolism , Disease Models, Animal , Disease Progression , Female , Gene Expression Profiling , Herpesviridae Infections/complications , Herpesviridae Infections/genetics , Intercellular Adhesion Molecule-1/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Protein Kinase Inhibitors/pharmacology , RNA, Messenger/metabolism , Time Factors , Up-Regulation , Vascular Cell Adhesion Molecule-1/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/genetics
8.
Korean J Gastroenterol ; 55(1): 62-7, 2010 Jan.
Article in Korean | MEDLINE | ID: mdl-20098069

ABSTRACT

Gastrointestinal complications (GI) after thoracoabdominal aortic repair can be classified as biliary disease, heptic dysfunction, pancreatitis, GI bleeding, peptic ulcer disease, bowel ischemia, paralytic ileus, and aortoenteric fistula. Theses complications are associated with high post operative morbidity and mortality. Most of the aortoenteric fistulae after thoracoabdominal aortic surgery are found at the duodenum, near the surgical site. These rare complications are caused by an indirect communication with abdominal aorta that originated from an aneursymal formation ruptured into the duodenum. Such aorto-duodenal fistula formation is considered as a result of inflammatory change from secondary infection near the surgical instruments. Herein, we report two cases of massive upper GI bleeding from aorto-duodenal fistulae and spontaneous lower GI perforation related to cytomegalovirus infection after abdominal aortic aneurysmal repair operations.


Subject(s)
Aorta, Abdominal/surgery , Aortic Aneurysm, Abdominal/surgery , Aortic Diseases/diagnosis , Cytomegalovirus Infections/complications , Intestinal Fistula/diagnosis , Intestinal Perforation/diagnosis , Vascular Fistula/diagnosis , Aged , Aged, 80 and over , Aortic Aneurysm, Abdominal/complications , Aortic Diseases/surgery , Aortic Diseases/virology , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/pathology , Endoscopy, Gastrointestinal , Gastrointestinal Hemorrhage/etiology , Humans , Intestinal Fistula/surgery , Intestinal Fistula/virology , Intestinal Perforation/virology , Male , Vascular Fistula/surgery , Vascular Fistula/virology
9.
Eur J Vasc Endovasc Surg ; 35(2): 153-8, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17964192

ABSTRACT

OBJECTIVES: The aim of this case control study was to evaluate whether periodontitis was associated with peripheral arterial disease (PAD). SUBJECTS AND METHODS: Twenty-five patients diagnosed with aorto-iliac and/or femoro-popliteal occlusive disease and thirty-two generally healthy control subjects were enrolled in this study. Polymerase chain reaction (PCR) was used to identify Porphyromonas gingivalis, Treponema denticola, Actinobacillus actinomycetemcomitans, Prevotella intermedia, Cytomegalovirus (CMV), Chlamydia pneumoniae, and Helicobacter pylori in tissue specimens taken from the anastomotic site of distal bypasses. Periodontal status was evaluated; serum IgG titres against the four listed bacteria were measured. RESULTS: Periodontopathic bacteria were detected in 13/25 (52%) atherosclerotic specimens. CMV or C. pneumoniae was detected in 1/25 (4%) specimens; H. pylori was not detected from any of these specimens. Fontaine grade III or IV patients showed higher detection frequency of P. gingivalis than Fontaine grade II patients (57.1% vs 22.2%, P=0.09). After adjusting for age, gender, diabetes and smoking, periodontitis increased 5-fold the risk of having PAD (OR 5.45). There were preliminary indications that periodontitis was associated with increased serum IL-6 and TNF-alpha concentrations. CONCLUSIONS: This study suggests that periodontitis may be associated with an increased risk of PAD. This association could result from the increased concentration of serum inflammatory cytokines in those with periodontitis.


Subject(s)
Aortic Diseases/etiology , Arterial Occlusive Diseases/etiology , Femoral Artery , Iliac Artery , Periodontitis/complications , Peripheral Vascular Diseases/etiology , Popliteal Artery , Aged , Anastomosis, Surgical , Antibodies, Bacterial/blood , Antibodies, Viral/blood , Aortic Diseases/microbiology , Aortic Diseases/surgery , Aortic Diseases/virology , Arterial Occlusive Diseases/microbiology , Arterial Occlusive Diseases/surgery , Arterial Occlusive Diseases/virology , Case-Control Studies , Female , Femoral Artery/microbiology , Femoral Artery/surgery , Femoral Artery/virology , Humans , Iliac Artery/microbiology , Iliac Artery/surgery , Iliac Artery/virology , Interleukin-1beta/blood , Interleukin-6/blood , Male , Middle Aged , Odds Ratio , Periodontitis/microbiology , Periodontitis/surgery , Periodontitis/virology , Peripheral Vascular Diseases/microbiology , Peripheral Vascular Diseases/surgery , Peripheral Vascular Diseases/virology , Popliteal Artery/microbiology , Popliteal Artery/surgery , Popliteal Artery/virology , Risk Assessment , Risk Factors , Severity of Illness Index , Tumor Necrosis Factor-alpha/blood , Vascular Surgical Procedures
10.
Pediatr Dev Pathol ; 7(1): 61-70, 2004.
Article in English | MEDLINE | ID: mdl-15255036

ABSTRACT

Arteriopathy in human immunodeficiency virus (HIV)-infected patients is being increasingly recognized, especially in children. However, few studies have histologically evaluated the coronary arteries in HIV-infected children, and none have systematically assessed the aorta and pulmonary arteries. The coronary arteries, thoracic aorta, and the main and branch pulmonary arteries from the postmortem hearts of 14 HIV-infected children were systematically reviewed for vasculopathic lesions and compared with 14 age-matched controls. Findings from the HIV-infected children were compared with clinical, laboratory, and other postmortem findings. Coronary arteriopathy, seen in seven (50%) of the HIV-infected children, was primarily calcific, and it was associated with decreased CD3 and CD4 peripheral blood counts. Large vessel arteriopathy, seen in 9 (64%) of the 14 HIV-infected children, was primarily centered on the vasa vasorum and consisted mainly of medial hypertrophy and chronic inflammation. Large vessel lesions were associated with increased left ventricular mass z-scores (P = 0.02), and 78% of patients with large vessel arteriopathy had postmortem cardiomegaly. Coronary and large vessel arteriopathies are common in pediatric HIV-infection and have different clinicopathologic features suggesting different pathogenesis.


Subject(s)
Aortic Diseases/virology , Coronary Disease/virology , HIV Infections/complications , Pulmonary Artery , Vascular Diseases/virology , Aorta/pathology , Aortic Diseases/complications , Aortic Diseases/pathology , Cadaver , Child , Child, Preschool , Chronic Disease , Coronary Disease/complications , Coronary Disease/diagnostic imaging , Coronary Disease/pathology , Coronary Vessels/pathology , Echocardiography , Female , HIV Infections/immunology , Heart Diseases/complications , Humans , Immune Tolerance , Infant, Newborn , Male , Prospective Studies , Pulmonary Artery/pathology , Vascular Diseases/complications , Vascular Diseases/pathology
12.
J Heart Lung Transplant ; 16(10): 1035-45, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9361246

ABSTRACT

BACKGROUND: Cytomegalovirus has been implicated in the development of allograft vasculopathy in heart transplant recipients. Given that allograft vasculopathy is a form of chronic rejection, it is conceivable that cytomegalovirus somehow alters the allogeneic response to the vasculature. Prior work has demonstrated that smooth muscle cells (SMCs) are highly permissive for cytomegalovirus and exhibit cytopathologic characteristics and alterations in MHC class I antigens in response to cytomegalovirus at a high multiplicity of infection (MOI). METHODS: To determine whether cytomegalovirus at low, more clinically relevant MOI, can alter SMCs phenotypically, human aortic SMCs were infected with approximately 1 plaque forming units/3000 cells of cytomegalovirus strain AD169. RESULTS: One week after infection, human aortic SMCs (compared with human foreskin fibroblasts) demonstrated no cytopathologic characteristics (n = 6), released reduced amounts of intact virion into the culture media (assessed by exposing naive monolayers of human foreskin fibroblasts to media and staining for cytomegalovirus immediate-early antigen, n = 3), yet had at least, if not greater detectable total cytomegalovirus vital DNA levels. Infected HASMCs uniformly increased their expression of MHC class I antigen by 55% +/- 21% above constitutive levels (assessed by flow cytometry (n = 5, p < 0.0001). Cytomegalovirus infection resulted in an increase in interleukin-6 mRNA expression compared to control (297 +/- 63 vs 188 +/- 50, respectively; p = 0.02, n = 6) and reduced the expression of transforming growth factor-beta mRNA (802 +/- 152 vs 1201 +/- 236, respectively; p = 0.05). CONCLUSIONS: These data suggest that low MOI of cytomegalovirus can infect SMCs without producing cell cytolysis and, in spite of this lack of overt infection, modulate cell surface antigens and cytokine mRNA levels that can influence allogeneic responses.


Subject(s)
Aortic Diseases/virology , Cytokines/analysis , Cytomegalovirus Infections/immunology , Cytomegalovirus/immunology , Histocompatibility Antigens Class I/analysis , Muscle, Smooth, Vascular/virology , Antigens, Viral/analysis , Antigens, Viral/immunology , Aortic Diseases/immunology , Cells, Cultured , Chronic Disease , Coloring Agents , Coronary Disease/virology , Culture Media , Cytokines/immunology , Cytomegalovirus/physiology , Cytopathogenic Effect, Viral , DNA, Viral/analysis , Fibroblasts/immunology , Fibroblasts/virology , Gene Expression Regulation, Viral , Graft Rejection/virology , Heart Transplantation/immunology , Histocompatibility Antigens Class I/immunology , Humans , Immediate-Early Proteins/analysis , Immediate-Early Proteins/immunology , Interleukin-6/analysis , Interleukin-6/genetics , Muscle, Smooth, Vascular/immunology , Phenotype , RNA, Messenger/analysis , RNA, Messenger/genetics , Transforming Growth Factor beta/analysis , Transforming Growth Factor beta/genetics , Transplantation, Homologous , Virion/metabolism , Virus Replication
13.
Am J Pathol ; 149(6): 1887-98, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8952525

ABSTRACT

Clinical and serological studies provide evidence for a pathogenetically relevant vasculopathy in acquired immune deficiency syndrome (AIDS); however, the morphological status of the endothelium under conditions of human immunodeficiency virus (HIV)-1 infection is only sparsely documented. In this study we adapted an en face preparation technique of endothelium for use in immunohistochemistry and investigated the aortic endothelium of pre-AIDS and AIDS patients (n = 32) in comparison with an HIV-negative group (n = 17). The control group showed a regular pattern of evenly distributed aortic endothelial cells, whereas the endothelial cell pattern in the HIV-1-infected patients was clearly disturbed. Simultaneously, the degree of leukocyte adherence on the aortic endothelium increased significantly. These changes were accompanied by an up-regulation of the vascular cell adhesion molecule-1 (VCAM-1) and E-selectin (ELAM-1). The endothelium turnover increased, and one-half of the HIV-1-infected patients exhibited HLA-DR (major histocompatibility complex class II) antigen in the aortic endothelium. Our results provide evidence for a profound and repeated injury with regeneration and activation of the endothelium in HIV-1 infection. Injury as well as activation of the endothelium impairs its normal regulatory properties. This could have consequences for the maintenance of the blood-brain barrier; it might influence the immunologically important interaction of the endothelium with T cells; and it might trigger Kaposi's sarcoma.


Subject(s)
Acquired Immunodeficiency Syndrome/pathology , Aortic Diseases/pathology , Endothelium, Vascular/pathology , HIV-1/growth & development , Leukocytes/pathology , Virus Activation , Adolescent , Adult , Antibodies, Monoclonal/immunology , Aorta/pathology , Aorta/virology , Aorta, Abdominal/pathology , Aorta, Abdominal/virology , Aortic Diseases/virology , Cell Adhesion , Cell Division , Child , E-Selectin/biosynthesis , Endothelium, Vascular/virology , Female , HLA-DR Antigens/biosynthesis , Humans , Immunohistochemistry , Intercellular Adhesion Molecule-1/biosynthesis , Interleukin-1/biosynthesis , Ki-67 Antigen/analysis , Leukocytes/virology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL